Expressionist paints picture of cancer genetics

Related tags Gene expression Organism

Genedata's Expressionist software is to be used in a cancer
research effort in Singapore aimed at developing clinical
diagnostics and identifying novel drug targets.

Swiss software firm Genedata has entered into a collaboration with National Cancer Centre Singapore aimed at conducting gene expression analyses for cancer research. As part of the agreement, the NCCS has licensed Genedata's Expressionist system for the analysis of microarrays.

Genedata's software system is designed to enable scientists to handle the vast amount of data that is generated from experiments using high-density microarrays and other techniques.

Researchers at the NCCS will use Expressionist in a project that aims to develop commercially viable clinical diagnostics, based on the identification of cancer-related diagnostic marker genes.

The software will also be used to identify the function of genes involved in tumour development and progression, understand the biological processes that are critical for tumour progression and characterise oncogenic signal transduction pathways, all of which may lead to the identification of new targets for drug discovery.

Related topics Preclinical Research

Related news

Follow us

Products

View more

Webinars